Real-World Evidence of the Incidence of and Risk Factors for Type 1 Diabetes Mellitus and Hypothyroidism as Immune-Related Adverse Events Associated With Programmed Cell Death-1 Inhibitors
- Resource Type
- Article
- Source
- In
Endocrine Practice June 2021 27(6):586-593 - Subject
- Language
- ISSN
- 1530-891X